Annual Current Assets
$187.37 M
+$84.15 M+81.53%
December 31, 2024
Summary
- As of March 12, 2025, SLN annual total current assets is $187.37 million, with the most recent change of +$84.15 million (+81.53%) on December 31, 2024.
- During the last 3 years, SLN annual current assets has risen by +$70.85 million (+60.80%).
- SLN annual current assets is now at all-time high.
Performance
SLN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$187.37 M
-$23.42 M-11.11%
December 1, 2024
Summary
- As of March 12, 2025, SLN quarterly total current assets is $187.37 million, with the most recent change of -$23.42 million (-11.11%) on December 1, 2024.
- Over the past year, SLN quarterly current assets has stayed the same.
- SLN quarterly current assets is now -18.34% below its all-time high of $229.44 million, reached on March 31, 2024.
Performance
SLN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
SLN Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +81.5% | 0.0% |
3 y3 years | +60.8% | 0.0% |
5 y5 years | +281.4% | 0.0% |
SLN Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +81.5% | -18.3% | +110.3% |
5 y | 5-year | at high | +281.4% | -18.3% | +281.4% |
alltime | all time | at high | +6521.4% | -18.3% | >+9999.0% |
Silence Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $15.27 M(-6.4%) | - |
Dec 2024 | - | $187.37 M(-11.1%) |
Sep 2024 | - | $210.78 M(-5.5%) |
Jun 2024 | - | $223.08 M(-2.8%) |
Mar 2024 | - | $229.44 M(+122.3%) |
Dec 2023 | $16.31 M(+24.6%) | $103.21 M(-3.4%) |
Sep 2023 | - | $106.88 M(+2.9%) |
Jun 2023 | - | $103.82 M(+0.2%) |
Mar 2023 | - | $103.64 M(-11.4%) |
Dec 2022 | $13.09 M(-1.7%) | $117.01 M(-7.6%) |
Sep 2022 | - | $126.70 M(+42.2%) |
Jun 2022 | - | $89.09 M(-11.8%) |
Mar 2022 | - | $101.03 M(-13.3%) |
Dec 2021 | $13.31 M(+2.0%) | $116.52 M(+4.4%) |
Sep 2021 | - | $111.62 M(-11.7%) |
Jun 2021 | - | $126.42 M(+21.4%) |
Dec 2020 | $13.04 M(+15.5%) | $104.12 M(-6.7%) |
Jun 2020 | - | $111.64 M(+127.3%) |
Dec 2019 | $11.29 M(-5.2%) | - |
Dec 2019 | - | $49.12 M(+86.8%) |
Jun 2019 | - | $26.30 M(-29.7%) |
Dec 2018 | $11.91 M(-6.8%) | - |
Dec 2018 | - | $37.43 M(-25.3%) |
Jun 2018 | - | $50.10 M(-18.6%) |
Dec 2017 | $12.78 M(-24.8%) | - |
Dec 2017 | - | $61.55 M(+42.5%) |
Jun 2017 | - | $43.18 M(-16.7%) |
Dec 2016 | $17.00 M(+43.6%) | - |
Dec 2016 | - | $51.83 M(-22.6%) |
Jun 2016 | - | $66.99 M(-15.6%) |
Dec 2015 | $11.84 M(+1.0%) | - |
Dec 2015 | - | $79.33 M(-10.1%) |
Jun 2015 | - | $88.28 M(+155.1%) |
Dec 2014 | $11.73 M(-11.3%) | - |
Dec 2014 | - | $34.61 M(-24.8%) |
Jun 2014 | - | $46.00 M(+31.1%) |
Dec 2013 | $13.22 M | - |
Dec 2013 | - | $35.09 M(-7.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2013 | - | $38.12 M(+160.4%) |
Dec 2012 | $12.95 M(-71.8%) | - |
Dec 2012 | - | $14.64 M(+776.8%) |
Jun 2012 | - | $1.67 M(-72.4%) |
Dec 2011 | $45.86 M(+0.5%) | - |
Dec 2011 | - | $6.05 M(-45.5%) |
Jun 2011 | - | $11.11 M(+64.4%) |
Dec 2010 | $45.65 M(+205.4%) | - |
Dec 2010 | - | $6.75 M(-39.5%) |
Jun 2010 | - | $11.16 M(+294.2%) |
Dec 2009 | $14.95 M(+2.5%) | - |
Dec 2009 | - | $2.83 M(-54.5%) |
Jun 2009 | - | $6.22 M(-3.9%) |
Dec 2008 | $14.59 M(-6.1%) | - |
Dec 2008 | - | $6.47 M(-51.2%) |
Jun 2008 | - | $13.25 M(-42.6%) |
Dec 2007 | $15.53 M(+11.4%) | - |
Dec 2007 | - | $23.09 M(+54.3%) |
Jun 2007 | - | $14.97 M(-20.7%) |
Dec 2006 | $13.94 M(+8.0%) | - |
Dec 2006 | - | $18.88 M(+37.0%) |
Jun 2006 | - | $13.78 M(-17.2%) |
Dec 2005 | $12.91 M(>+9900.0%) | - |
Dec 2005 | - | $16.64 M(+265.2%) |
Jun 2005 | - | $4.56 M(-24.6%) |
Dec 2004 | $76.70 K(-28.4%) | - |
Dec 2004 | - | $6.04 M(-20.2%) |
Jun 2004 | - | $7.57 M(-34.0%) |
Dec 2003 | $107.10 K(-7.7%) | - |
Dec 2003 | - | $11.48 M(-3.7%) |
Jun 2003 | - | $11.92 M |
Dec 2002 | $116.00 K(+9.3%) | - |
Dec 2001 | $106.10 K(-22.8%) | - |
Dec 2000 | $137.40 K(+2013.8%) | - |
Dec 1999 | $6500.00(-35.0%) | - |
Dec 1998 | $10.00 K(-83.7%) | - |
Dec 1997 | $61.20 K(-45.0%) | - |
Dec 1996 | $111.30 K(+3490.3%) | - |
Dec 1995 | $3100.00 | - |
FAQ
- What is Silence Therapeutics annual total current assets?
- What is the all time high annual current assets for Silence Therapeutics?
- What is Silence Therapeutics annual current assets year-on-year change?
- What is Silence Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Silence Therapeutics?
- What is Silence Therapeutics quarterly current assets year-on-year change?
What is Silence Therapeutics annual total current assets?
The current annual current assets of SLN is $187.37 M
What is the all time high annual current assets for Silence Therapeutics?
Silence Therapeutics all-time high annual total current assets is $187.37 M
What is Silence Therapeutics annual current assets year-on-year change?
Over the past year, SLN annual total current assets has changed by +$84.15 M (+81.53%)
What is Silence Therapeutics quarterly total current assets?
The current quarterly current assets of SLN is $187.37 M
What is the all time high quarterly current assets for Silence Therapeutics?
Silence Therapeutics all-time high quarterly total current assets is $229.44 M
What is Silence Therapeutics quarterly current assets year-on-year change?
Over the past year, SLN quarterly total current assets has changed by $0.00 (0.00%)